Astellas Pharma total depreciation and amortization - cash flow for the twelve months ending December 31, 2024 was $0.940B, a 53.14% increase year-over-year.
Astellas Pharma annual total depreciation and amortization - cash flow for 2024 was $1.045B, a 31.45% increase from 2023.
Astellas Pharma annual total depreciation and amortization - cash flow for 2023 was $0.795B, a 21.75% increase from 2022.
Astellas Pharma annual total depreciation and amortization - cash flow for 2022 was $0.653B, a 0.31% decline from 2021.
Astellas Pharma Total Depreciation and Amortization - Cash Flow 2012-2024 | ALPMY